In a bold move, pharma giants push the EU to reconsider its current drug pricing policies. European pharmaceutical leaders urge the EU to propose alignment with US net prices to stimulate R&D and manufacturing investment amid growing competition. Major European pharmaceutical companies are intensifying calls for the European Union to permit higher medicine prices. They argue that current policies stifle…